The
NSDUH Report: Patterns of Hallucinogen Use and Initiation:
2004 and 2005
- HTML
format (also has the data table
used to construct each figure)
Highlights:
- Hallucinogens
include lysergic acid diethylamide (LSD), phencyclidine (PCP), Ecstasy
(MDMA), peyote, mescaline, and psilocybin (mushrooms).
- Combined
data from SAMHSA's 2004 and 2005 National Surveys on Drug Use and Health
indicate that an annual average of 943,000 persons aged 12 or older
were recent initiates of hallucinogens (i.e., they had used hallucinogens
for the first time in the 12 months before the survey).
- Of
these recent hallucinogen initiates, 52.3% had used psilocybin mushrooms
and 42.9% used Ecstasy in the past year.
- Recent
female hallucinogen initiates were more likely than recent male hallucinogen
initiates to have used Ecstasy (49.5% vs. 37.7%). In contrast, recent
male hallucinogen initiates were more likely than recent female hallucinogen
initiates to have used psilocybin mushrooms (61.1% vs. 41.1%).
Hallucinogens
Other
drugs
Other
topics
This Short Report,
The NSDUH Report: Patterns
of Hallucinogen Use and Initiation: 2004 and 2005, is based on SAMHSA's
National Survey on Drug Use and Health (NSDUH).
The NSDUH is conducted by the Office of Applied Studies
(OAS) in the Substance Abuse and Mental Health Services Administration
(SAMHSA). SAMHSA's National Survey on Drug Use and Health (NSDUH)
is the primary source of information on the prevalence, patterns, and consequences
of drug and alcohol use and abuse in the general U.S. civilian non institutionalized
population, age 12 and older. SAMHSA's
National Survey on Drug Use & Health also provides estimates for drug use
by State. |